CGRP Therapies for Migraine Effect on Quality of Life

Survey finds positive HCP relationships, negative quality of life for chronic migraine patients who currently use vs. never used CGRP therapies.

CFTR Modulator Use Among Cystic Fibrosis Patients

A Cystic Fibrosis survey finds patients who have never used a CFTR modulator are more likely to say CF negatively impacts their overall quality of life.

Health Union Ranks No. 209 on 2019 Deloitte 500™

Health Union has ranked among Deloitte Technology Fast 500 ™ for the second consecutive year due to exponential growth since the company started in 2010.

Survey of Adults with Atopic Dermatitis Symptoms As Kids

84% of survey respondents who experienced atopic dermatitis symptoms as kids said they were diagnosed more than 10 years ago.

Alzheimer’s Disease Caregivers Type and Level of Care

A new Health Union survey finds the experiences of caregivers of people with Alzheimer’s disease differ greatly as the condition progresses.

Likely Indicators of DMT Use Among Multiple Sclerosis Patients

The “Multiple Sclerosis In America 2019” survey uncovers the behaviors of people living with multiple sclerosis using a disease-modifying therapy (DMT).

No. 906 on Inc. 5000 Fastest-Growing Companies of 2019

For the second consecutive year, Health Union has been recognized by Inc. magazine’s annual Inc. 5000 list with a three-year growth of 469%.

More Positive Experiences When Fewer Doctors Needed to Diagnose Ankylosing Spondylitis

People with ankylosing spondylitis who consulted four or more HCPs while seeking a diagnosis experience more difficult patient journeys.

Health Union Welcomes Will Rompala as Chief Technology Officer

Rompala will leverage more than two decades of experience to provide a strategic roadmap for evolving Health Union’s technological and data capabilities.

Females with Bladder Cancer Receive Less Support Than Men

Survey shows males with bladder cancer are more likely to receive various types of condition management support than females with bladder cancer.